A major development in the global renal care market.
Rockwell Medical has announced plans to acquire Vantive’s haemodialysis concentrates, dialysis machines, water treatment systems and associated consumables and technical services business.
The deal would significantly broaden Rockwell Medical’s existing dialysis portfolio and global footprint, including the acquisition of Vantive’s one-million-square-foot manufacturing facility in Medolla, Italy.
If completed, the combined business is expected to generate annual revenues of between $400m and $450m, positioning Rockwell Medical as one of the world’s largest haemodialysis providers.
For Vantive, the agreement represents the transfer of a substantial part of its haemodialysis operation, while Rockwell gains established technology, manufacturing capability, international distribution and recurring service and consumable revenues.
The transaction has a base purchase price of $125m, with up to a further $45m linked to future revenue and EBITDA milestones, and is expected to complete in mid-2027, subject to regulatory approvals and other closing conditions.
Another interesting shift in the renal market — and one we’ll be watching closely given the potential implications for teams, product portfolios and commercial structures across the sector.
#MedTech #RenalCare #Dialysis #Haemodialysis #MedicalDevices #Healthcare #MedTechNews